Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation

Haematologica

Volumn 95, Issue 11, 2010, Pages 1897-1904

  Boggio, Elena ^a   Indelicato, Manuela ^b   Orilieri, Elisabetta ^a   Mesturini, Riccardo ^a   Mazzarino, Maria Clorinda ^c   Campagnoli, Maria Francesca ^d   Ramenghi, Ugo ^d   Dianzani, Umberto ^a   Chiocchetti, Annalisa ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Apoptosis; Autoimmunity; Lymphoproliferation; Osteopontin; Tissue inhibitor of metalloproteinases 1

Indexed keywords

FAS ANTIGEN; OSTEOPONTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

APOPTOSIS; ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; PATHOGENESIS; PROTEIN BLOOD LEVEL; SUPERNATANT; T LYMPHOCYTE;

ADOLESCENT; APOPTOSIS; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC VARIATION; HUMANS; MALE; OSTEOPONTIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 78149253601     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.023085     Document Type: Article

References (33)

1. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999;130(7):591-601.
2. Bleesing JJ, Brown MR, Dale JK, Straus SE, Lenardo MJ, Puck JM, et al. TcRalpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol. 2001;100 (3):314-24.
3. Nagata S. Apoptosis by death factor. Cell. 1997;88(3):355-65.
4. Campagnoli MF, Garbarini L, Quadrello P, Garelli E, Carando A, Baravalle V, et al. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients. Haematologica. 2006;91(4):538-41.
5. Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci USA. 1999;96(8):4552-7.
6. Dianzani U, Bragardo M, DiFranco D, Alliaudi C, Scagni P, Buonfiglio D, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood.1997;89(8):2871-9.
7. Ramenghi U, Bonissoni S, Migliaretti G, DeFranco S, Bottarel F, Gambaruto C, et al. Deficient of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood. 2000;95(10):3176-82.
8. Oliveira JB, Bidère N, Niemela JE, Zheng L, Sakai K, Nix CP, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104(21):8953-8.
9. Rieaux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268(5215):1347-9.
10. Chiocchetti A, Indelicato M, Bensi T, Mesturini R, Giordano M, Sametti S, et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood. 2004;103(4):1376-82.
11. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001;107(9):1055-61.
12. O'Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today. 2000;21(10):475-8.
13. Hashimoto M, Sun D, Rittling SR, Denhardt DT, Young W. Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J Neurosci. 2007;27(13):3603-11.
14. Mateo V, Ménager M, de Saint-Basile G, Stolzenberg MC, Roquelaure B, André N, et al. Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes. Blood. 2007;110(13):4285-92.
15. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-39.
16. Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler-Stevenson M, et al. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood. 2005; 105(4):1660-8.
17. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest. 1998;102 (11):2002-10.
18. Guedez L, Courtemanch L, Stetler-Stevenson M. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood. 1998;92(4):1342-9.
19. Dono M, Zupo S, Augliera A, Bugio VL, Massara R, Melagrana A, et al. Subepithelial B cells in the human palatine tonsil. II. Functional characterization. Eur J Immunol. 1996;26(9):2043-9.
20. Indelicato M, Chiarenza V, Libra M, Malaponte G, Bevelacqua V, Marchini M, et al. Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients. J Clin Lab Anal. 2006;20(5):173-6.
21. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 1994;107(Pt 9):2373-9.
22. Lambert E, Dassé E, Haye B, Petitfrère E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004;49(3):187-98.
23. Guo LJ, Luo XH, Xie H, Zhou HD, Yuan LQ, Wang M, et al. Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1. Calcif Tissue Int. 2006;78 (5):285-92.
24. Xie H, Tang LL, Luo XH, Wu XY, Wu XP, Zhou HD, et al. Suppressive effect of dexamethasone on TIMP-1 production involves murine osteoblastic MC3T3-E1 cell apoptosis. Amino Acids. 2010;38(4): 1145-53.
25. Pfistershammer K, Majdic O, Stöckl J, Zlabinger G, Kirchberger S, Steinberger P, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173 (10):6000-8.
26. Jung KK, Liu XW, Chirco R, Fridman R, Kim HR. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 2006;25(17): 3934-42.
27. Oelmann E, Herbst H, Zühlsdorf M, Alberecht O, Nolte A, Schmitmann C, et al. Tissue inhibitors of metalloproteinase 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood. 2002;99(1):258-67.
28. Lambert E, Bridoux L, Devy J, Dassé E, Sowa ML, Duca L, et al. TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival. Int J Biochem Cell Biol. 2009;41(5): 1102-15.
29. Marroquin CE, Downey L, Guo H, Kuo PC. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells. Immunol Lett. 2004;95(1): 109-12.
30. Khan SA, Cook AC, Kappil M, Günthert U, Chambers AF, Tuck AB, et al. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel posttranscriptional, post-translational regulation. Clin Exp Metastasis. 2005;22(8):663-73.
31. Lopatin U, Yao X, Williams RK, Bleesing JJ, Dale J, Wong D, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 2001;97(10):3161-70.
32. Guedez L, Mansoor A, Birkedal-Hansen B, Lim MS, Fukushima P, Venzon D, et al. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cells differentiation and lymphomagenesis. Blood. 2001;97(6):1796-802.
33. Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis. Br J Dermatol. 2004;151(2):407-12.